Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 28, 2014; 20(40): 14927-14933
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14927
Effect of somatostatin in advanced gastric cancer after D2 radical gastrectomy
Wu Song, Jian-Hui Chen, Xin-Hua Zhang, Jian-Bo Xu, Yu-Long He, Shi-Rong Cai, Fang-Hai Han, Chuang-Qi Chen
Wu Song, Jian-Hui Chen, Xin-Hua Zhang, Jian-Bo Xu, Yu-Long He, Shi-Rong Cai, Fang-Hai Han, Chuang-Qi Chen, Gastric Cancer Center, Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China
Wu Song, Jian-Hui Chen, Xin-Hua Zhang, Jian-Bo Xu, Yu-Long He, Shi-Rong Cai, Fang-Hai Han, Chuang-Qi Chen, Division of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, Guangdong Province, China
Author contributions: Song W and Chen JH contributed equally to this work; Song W, Chen JH and He YL designed research; Song W, Zhang XH, Xu JB, He YL, Cai SR, Han FH and Chen CQ performed research; Chen JH, Zhang XH and Xu JB analyzed data; and Song W and Chen JH wrote the paper.
Supported by Guangdong Province Science and Technology Plan Project, No. 2011B031800240 and No. 2012B031800389; and Guangdong Province Natural Science Fund, No. 52013010015528
Correspondence to: Yu-Long He, MD, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Zhongshan Road No 2, Guangzhou 510080, Guangdong Province, China. ylh@medmail.com.cn
Telephone: +86-20-87755766 Fax: +86-20-87331509
Received: March 27, 2014
Revised: May 15, 2014
Accepted: July 22, 2014
Published online: October 28, 2014
Abstract

AIM: To study the effect of somatostatin in patients with advanced gastric cancer who received D2 lymphadenectomy and vagina vasorum dissection.

METHODS: Using a prospective, single-blind, placebo-controlled design, patients with advanced gastric cancer were randomized into a study group (n = 61) and a control group (n = 59). Patients in the study group were given somatostatin for 5-7 d starting 6 h after the operation, and patients in the control group were given normal saline. Preoperative and nonoperative complications in the perioperative period, as well as different types of postoperative drainage in the two groups were compared.

RESULTS: There was no significant difference between the study group and the control group for preoperative clinicopathological indicators. We found no significant difference between the two groups for the overall incidence of complications, but a lower percentage of peritoneal effusion was observed in the treatment group (1.6% vs 10.2%, P < 0.05). There were no significant differences between the two groups in the incidence of postoperative pancreatic dysfunction and chylous fistula. However, there were significant differences in the amylase concentration in drainage fluid, volume and duration of drainage, volume and duration of chylous fistula and peritoneal drainage, and volume and duration of gastric tube drainage. The study group did not show any increase in mean hospitalization cost and the cost reduced when the postoperative complications occurred.

CONCLUSION: Postoperative somatostatin reduces volume and duration of surgical drainage and related complications. Somatostatin may improve safety of gastric cancer surgery, reducing postoperative complications and promoting recovery.

Keywords: Advanced gastric cancer, Somatostatin, Complications

Core tip: To enhance the degree of radical lymph nodes dissection for advanced gastric cancer, vagina vasorum dissection and the resection of extracapsular greater omentum was applied to D2 lymph node dissection. Vagina vasorum dissection was the complete removal of vascular adventitia and fibrous connective tissue as well as nerve tissue around the vascular sheath. But these procedure usually followed by operation-related complications. Hence It is interesting to found out the clinical effect of postoperative somatostatin treatment in the duration and amount of drain followed by gastrectomy and D2 lymphadenectomy with extra capsular epiploon resection.